Sector
PharmaceuticalsOpen
₹8Prev. Close
₹8Turnover(Lac.)
₹0Day's High
₹8Day's Low
₹852 Week's High
₹052 Week's Low
₹0Book Value
₹-17.4Face Value
₹10Mkt Cap (₹ Cr.)
4.13P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Equity Capital | 5.16 | 5.16 | 5.16 | 5.16 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -10.85 | -10.74 | -23.51 | -21.29 |
Net Worth | -5.69 | -5.58 | -18.35 | -16.13 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | 0 | 0 | 0 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Profit before tax | -0.1 | -0.14 | -0.24 | -0.16 |
Depreciation | -0.02 | -0.03 | -0.04 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.01 | -0.01 | -0.01 | -0.02 |
Other operating items |
| Y/e 31 Mar | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | -25.87 | -46.54 | 21.98 | -58.81 |
EBIT growth | -26.21 | -43.04 | 47.17 | -58.81 |
Net profit growth | -26.21 | -91.87 | 930.62 | -58.79 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,797.8 | 154.71 | 4,26,517.78 | 863.29 | 0.76 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,999.4 | 86.35 | 1,58,636.06 | 518 | 0.5 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,486.3 | 27.95 | 1,18,365.23 | 1,178.16 | 0.89 | 3,969.86 | 360.74 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,170.55 | 64.22 | 1,05,067.36 | 460 | 0.9 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,551.55 | 51.02 | 1,02,273.02 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Director
Ramesh Haridass
Director
Urvashi Ramesh
Independent Director
Rajath Patankar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by New Heaven Chemicals & Industries Ltd
Summary
No Record Found
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
